DISCOVER
User Support
User support
is available in both
French
and english
This service falls within the scope of the ISO 9001 quality management system. Under the applicable contractual conditions, it participates in the Service Level Agreement.
The service is provided by our operational teams (levels 1 and 2) and technical teams (level 3).
Access H24
via the WEB Portal
Please address your support requests via the WEB portal. You must have an access account.
Connexion
If you do not have an access account:
Request an access account
Email: hotline@tentelemed.com
Hotline
You can also access support via the hotline service.
Call number:
Unless it is specified in the contract, the hotline is available during business hours: 9.30 a.m. – 6 p.m. (Paris – GMT+1)
Remote call-out
Our hotliners have a commercial platform allowing, with the authorisation of the user, remote
Access requestto the “hotline” portal
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
2 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
May 22, 2023
Wednesday may 24 TELEMEDICINE TECHNOLOGIES will be present at SantExpo on the OVHcloud stand as a partner of the “Open Trusted Cloud” program. Our president Yoani Matsakis will be representing Telemedicine Technologies, and wil intervene next to Mathieu Godart, CTO and co-founder of SÊMEIA and Emmanuel MEYRIEUX, Client Security manager at OVHcloud. Throughout the day you […]
May 22, 2023
Fierce Biotech The FDA seems to be satisfied that Pfizer’s RSV vaccine is safe and effective for administration in pregnant women to protect infants from severe disease. The agency’s confidence was revealed in briefing documents filed ahead of an advisory committee meeting set for Thursday. The Vaccines and Related Biological Products Advisory Committee will consider […]
May 22, 2023
Trial Site News The World Health Organisation (WHO) decided Thursday May 4, 2023, to end the COVID-19 public health emergency of international concern (PHEIC). TrialSite cautions that this is a provisional (temporary) status while WHO considers its forward-looking options (2023-2025). Importantly, in “The COVID-19 Emergency is Over, Sort of,” TrialSite reports that in America some […]